X4 Pharmaceuticals (XFOR) Debt Ratio (2017 - 2025)

X4 Pharmaceuticals' Debt Ratio history runs 9 years deep, the most recent figure standing at 0.26 for Q4 2025.

• Quarterly Debt Ratio fell 49.87% year-over-year to 0.26 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.26 (down 49.87% YoY) and the FY2025 annual result came in at 0.26, down 49.87% from the prior year.
• Debt Ratio was 0.26 for Q4 2025 at X4 Pharmaceuticals, down from 0.47 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.71 in Q2 2025 and bottomed at 0.19 in Q2 2023.
• A 5-year average of 0.37 and a median of 0.34 in 2022 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 121.15% — and 2023, when it tumbled 62.95%.
• X4 Pharmaceuticals' Debt Ratio stood at 0.28 in 2021, then slipped by 23.51% to 0.22 in 2022, then jumped by 70.5% to 0.37 in 2023, then jumped by 38.98% to 0.52 in 2024, then tumbled by 49.87% to 0.26 in 2025.
• Business Quant data shows XFOR's Debt Ratio at 0.26 in Q4 2025, 0.47 in Q3 2025, and 0.71 in Q2 2025.